Cetera Investment Advisers’s BioNTech BNTX Stock Holding History

Cetera Investment Advisers’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,283	Closed	-$217K	–	4822
2025 Q4	$217K	Sell	2,283 -512	-18%	-$51.6K	﹤0.01%	4179
2025 Q3	$276K	Buy	+2,795	New	+$299K	﹤0.01%	3902
2024 Q4	–	Sell	-1,788	Closed	-$212K	–	3794
2024 Q3	$212K	Buy	+1,788	New	+$164K	﹤0.01%	3338
2024 Q2	–	Sell	-2,434	Closed	-$225K	–	3740
2024 Q1	$225K	Buy	+2,434	New	+$233K	﹤0.01%	3280
2022 Q3	–	Sell	-2,062	Closed	-$307K	–	1753
2022 Q2	$307K	Sell	2,062 -1,328	-39%	-$203K	﹤0.01%	1404
2022 Q1	$578K	Buy	3,390 +837	+33%	+$141K	0.01%	1075
2021 Q4	$658K	Buy	2,553 +265	+12%	+$72.6K	0.01%	1023
2021 Q3	$625K	Buy	2,288 +589	+35%	+$187K	0.01%	1007
2021 Q2	$380K	Buy	+1,699	New	+$320K	0.01%	1273

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cetera Investment Advisers's BNTX Position: Q1 2026 in Review

Cetera Investment Advisers sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 2,283 shares — an estimated $217K sold.

Cetera Investment Advisers first reported a position in BNTX in Q2 2021 and held it in 9 quarters. The position peaked at $658K in Q4 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

Cetera Investment Advisers reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
Cetera Investment Advisers sold 2,283 BioNTech shares in Q1 2026, an estimated $217K.
Cetera Investment Advisers first reported a position in BioNTech in Q2 2021 and held it in 9 quarters.
Cetera Investment Advisers's BioNTech position peaked at $658K in Q4 2021.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.